Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy

By | 2018-07-16T17:16:07+00:00 July 16th, 2018|Mesenchymal Stem Cells, Multiple Sclerosis|Comments Off on Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy

This open-label prospective phase I/IIa clinical study used autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs) followed by mesenchymal stromal cells conditioned media (MSC-CM) for the first time to treat multiple sclerosis (MS) patients.

[pdf-embedder url=”http://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Tx-of-MS-Sept.-2017.pdf” title=”MSC’s in Tx of MS Sept. 2017″]

About the Author: